Patent · US Active

Compositions and methods of treating Huntington's disease

US11752181B2 · kind B2 · utility

2Cited by

223References

21Claims

0Family size

Assignee

VOYAGER THERAPEUTICS, INC. · US

Inventors

Dinah Wen-Yee Sah · Boston, US
Fen Chen · Alexandria, US
Pengcheng Zhou · Lexington, US
Xin Wang · Beijing, CN
Yanqun Shu · Winchester, US
Jinzhao Hou · Cambridge, US
Jochen Deckert · Bayreuth, DE
Markus Hossbach · Kulmbach, DE

Key dates

Filing date	May 4, 2018
Grant date	Sep 12, 2023
Priority date	—
Expiry date	Apr 22, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.